Alexion is a Massachusetts-based pharmaceutical company that develops and commercializes immunoregulatory drugs for the treatment of autoimmune and cardiovascular diseases.
Business Model:
Revenue: $6.3B
Employees: 1,001-5,000
Alexion was acquired by
AstraZeneca.
The acquisition happend on 2020-12-12.
Details of the transaction were not public
Address: 121 Seaport Boulevard
City: Boston
State: MA
Zip: 02210
Country: US
Alexion is a Massachusetts-based pharmaceutical company that develops and commercializes immunoregulatory drugs for the treatment of autoimmune and cardiovascular diseases.
Contact Phone:
+14752302596
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
3/8/1996
Ticker Symbol:
ALXN
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
1/2015 | Moderna Therapeutics | Series E | 0 |
1/2014 | Moderna Therapeutics | Corporate Round | 0 |
1/2015 | Moderna Therapeutics | Series E | 0 |
1/2014 | Moderna Therapeutics | Corporate Round | 0 |
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 2/1999 | Post-IPO Equity | $5.8M | 2/1996 | IPO | $18M |
---|
Announced Date | Name | Price |
---|---|---|
5/2020 | Portola Pharmaceuticals | |
10/2019 | Achillion Pharmaceuticals | |
9/2018 | Syntimmune | |
4/2018 | Wilson Therapeutics | |
5/2015 | Synageva BioPharma | |
12/2011 | Enobia Pharma | |
1/2011 | Taligen Therapeutics | |
9/2000 | Prolifaron |
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|